Ampli®cation of genes in the 12q13-15 region occurs frequently in several malignancies including osteosarcoma. The products of these ampli®ed genes are thought to provide cancer cells with a selective growth advantage; however, the speci®c gene(s) driving this amplicon is unknown. We have previously shown that the SAS gene is ampli®ed in most parosteal osteosarcomas. In this study we analysed additional putative growth regulatory genes in this chromosomal region in 24 primary osteosarcoma specimens. CDK4 and SAS were coampli®ed in 6/6 parosteal tumors, and MDM2 was also ampli®ed in 4/5 parosteal cases. In comparison, ampli®cation occurred in only 2/16 classical intramedullary osteosarcomas and involved the SAS gene. Each ampli®ed gene had a correspondingly elevated mRNA level. Four high grade intramedullary tumors had elevated mRNA expression of SAS, but did not exhibit gene ampli®cation. Gene ampli®cation/overexpression was not associated with metastatic disease and did not change markedly with tumor progression, as evidenced by analysis of sequential tumor specimens from eight patients. Three other genes in the 12q13-15 region (CDK2, WNT1 and WNT10b) were not ampli®ed in any of the tumors. The di erent patterns of gene ampli®ca-tion and overexpression of CDK4, SAS and MDM2 in parosteal and intramedullary osteosarcomas may help explain the disparity in the biological behaviour of these two types of osteosarcoma.